The
report on global animal healthcare market provides qualitative and quantitative
analysis for the period of 2017 to 2023. According to the report the global
animal healthcare market value is growing with a CAGR between 4.5 % to 5.1 %
from 2017 to 2023. The global animal healthcare market size was totaled 35.09
Billion in 2016.
Figure 1: Global Animal Healthcare Market by Value 2015
- 2023
Market
Insights
Animal healthcare has become a substantial focus area
for many pharmaceutical players over past decade. This is due to progressive
growth registered by global animal healthcare market. Growth in this market can
be credible to animal disease outbreaks linked with large scale factory farming
that requires superior quality animal feed additives, vaccines and hygiene
management product. Rapidly increasing pet adoption, growing need to control
zoonotic disease spread and advance drug development for effective animal
health are the major growth driving factors in animal healthcare market. In
addition, favourable government initiatives and growing disposable income in
the emerging economies may results into pet adoption and spend on their health,
thereby significantly contributing in overall growth of this market. More
importantly, widespread implementation of animal vaccination programs with
mandatory vaccination certain countries expected propelling growth in the years
to come. Increasing incidences of zoonotic disease, however, in human due to
consumption of food animals will hamper industry growth.
Global animal healthcare markets will have numerous
growth opportunities during the forecasted period to grow significantly. This
can be attributed to growing demand for animal source protein that consequently
leads to animal farming and increasing R&D focus to develop new drugs for
pet cancer.
Segments Covered:
The
report segments the global animal healthcare market by pharmaceuticals type, by
vaccines, by medicated feed additives, by animal type and by region. The market
size of each segment has been provided in terms of value (USD) and volume (TONS).
Market segmentation based on pharmaceuticals includes ectoparaciticides,
endoparaciticides, anti-inflammatory, and anti-infective. On the basis of
vaccines global market has been divided into poultry, cattle, swine, equine,
dogs, cats and horse. Market segmentation based on medicated feed additives
includes antibiotics, vitamins, amino acids, enzymes, antioxidants, prebiotics
and probiotics, and minerals. And by type of animal market has been segmented
into farm animal and companion animal.
Geographic Coverage and Analysis:
The
report provides regional analysis covering geographies such as North America,
Europe, Asia-Pacific, and Rest of the World. In this section the key trends and
market size for each geography is provided over the period of 2017 – 2023.
Figure 2: Global Animal Healthcare Market by Region
On
the basis of geography, North America is the dominant region in global animal
healthcare market closely followed by Europe. North America and Europe
collectively accounted for the largest market share of more than 65% in 2015.
Moreover, U.S., Canada, Germany, UK, Spain, France, Italy are the vital
contributors from both of these regions. UK is one of the leading animal
healthcare markets and witnessed high growth, due to which Europe likely to
overtake North American market and dominate global market in the years to come.
Asia pacific considered as most growth attractive market on account of highest
production of meat in this region, and is consequently consume highest amount
of feed additive. The region will emerge as most lucrative one by registering
highest CAGR throughout the forecast period. This is due to contribution of
China and India in the regional growth of Asia Pacific, as these two markets
considered as most dynamic markets for meat production in the production.
Companies
Profiled:
The
companies covered in the report include Zoetis, Inc. (Pfizer), Merck &
Co., Inc. (Intervet), Eli Lilly and Company (Elanco/Novartis), Bayer Healthcare
AG, Ceva Santé Animale, Virbac S.A, Vetoquinol SA, Boehringer Ingelheim GmbH,
Nutreco N.V. and Sanofi S.A.
Report
Highlights:
The
report provides deep insights on demand forecasts, market trends and micro and
macro indicators. In addition, this report provides insights on the factors
that are driving and restraining the demand of animal
healthcare globally as well as regionally. Moreover, IGR-Growth Matrix
analysis given in the report brings an insight on the investment areas that
existing or new market players can consider.
The
report provides insights into the market using analytical tools such as Porter’s
five forces analysis and DRO analysis of animal healthcare. Moreover,
the study highlights current market trends and provides forecast from 2017 to
2023. We also have highlighted future trends in the animal healthcare
market that will impact the demand during the forecast period. Moreover,
the competitive analysis given in each regional market brings an insight on the
market share of the leading players. Additionally, the analysis highlights rise
and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the animal healthcare market to understand the present and future trends in this market and formulate their strategies accordingly.
Please Choose One of them.